Page 4 - Macip News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Much made it very difficult for doctors to recommend now the j&j vaccine, which is unfortunate because it is a very good vaccine in two doses and has even some advantages over mrna in terms of, i think, more durable and longer lasting protection because it stimulates a type of cell called cda positive cells. with the acip coming out with that statement it's going to be very hard to kind of walk it back. so right now i think a lot of the emphasis for the j&j vaccine is to try to do damage control to make certain that that doesn't contaminate enthusiasm for this vaccine globally because we reall...

Hospitalized again mostly among the unvaccinated. and about vaccination, just to refresh your memory, the pfizer is now authorized and recommended for children from 5 to 17. children from 12 to 17 can get a booster. the fda authorized 12 to 15 and today is acip will meet about that for recommendation. and finally, a question that many ask and i'm sure many reporters with children are asking this. what about kids from six months to five years? those studies are ongoing now to get the right dose and regimen to get to where we want to be and likely the clinical trial are ongoing and in individual...

Months up to 5 years of age. the ceo says he believes children of the age group will need three doses of the vaccine, that it's best to begin getting the first two doses while the company waits for data on the third dose. do you agree with that? >> i think what's happening, anderson, with this omicron wave, there's been so many cases that allows you to get a signal whether these vaccines are working and confirm that they're safe. so, i think what's happened with this omicron wave, there's enough confidence in the data to move forward and put it in front of the committee and the acip to see if ...

That allows you to get a signal whether these vaccines are working and confirm that they're safe. so, i think what's happened with this omicron wave, there's enough confidence in the data to move forward and put it in front of the committee and the acip to see if they agree that two doses is giving sufficient protection to move forward with the expectation that it would improve even more with the third dose. so, it's a little bit unconventional, but it may make sense if there's sufficient data to give some strong evidence that two doses is having an important effect. and with omicron, because ...

Members of the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices voted 14-0 to recommend the vaccine to younger kids.